S. Beers

发表

Heteroleptic phenyl benzimidazole complex

Chuanjun Xia, S. Layek, S. Beers, 2014 .

N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase.

T. Kirchner, D. Ritchie, M. Singer, 1997, Bioorganic & medicinal chemistry.

Novel hydroxyphosphonate inhibitors of CD-45 tyrosine phosphatase

John B. Moore, R. Look, S. Beers, 1997 .

6-Deoxycarbovir: A Xanthine Oxidase Activated Prodrug of Carbovir

R. Vince, J. Brownell, S. Beers, 1995 .

Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45.

J. Siekierka, J. Davis, D. Cavender, 1997, Bioorganic & medicinal chemistry.

Phosphatase inhibitors--III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase.

D. Loughney, S. Beers, E. Malloy, 1996, Bioorganic & medicinal chemistry.

Anti-AIDS agents. 291. Anti-HIV activity of modified podophyllotoxin derivatives

K. Lee, Hong Hu, S. Morris-Natschke, 1997 .

1-Naphthylmethylphosphonic acid derivatives as osteoclastic acid phosphatase inhibitors

L. Minor, K. Demarest, S. Beers, 1995 .

6-Substituted Derivatives of Carbovir: Anti-HIV Activity

W. Parker, R. Vince, B. Bowdon, 1995 .

Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Y. Cheng, K. Lee, J. Chang, 1990, Journal of medicinal chemistry.

Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.

R. Remmel, S. S. Ibrahim, R. Vince, 1992, Drug metabolism and disposition: the biological fate of chemicals.

Antitumor agents, 107. New cytotoxic 4-alkylamino analogues of 4'-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II.

Y. Cheng, K. Lee, M. Haruna, 1989, Journal of natural products.

Antitumor agents, 99. Synthetic ring C aromatized podophyllotoxin analogues as potential inhibitors of human DNA topoisomerase II.

K. Lee, Y. Imakura, S. Beers, 1988, Journal of natural products.

Benzylphosphonic acid inhibitors of human prostatic acid phosphatase

D. Wustrow, S. Beers, E. Malloy, 1996 .

RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

J. Siekierka, J. Davis, P. Schafer, 1999, The Journal of pharmacology and experimental therapeutics.